GoodRX Partners with DoorDash to Provide Dashers Discounted Prescription Drugs

GoodRX Partners with DoorDash to Provide Dashers Discounted Prescription Drugs

GoodRX (NASDAQ: GDRX), an American Healthcare company, has partnered with DoorDash to help gig and contract workers gain access to affordable prescription drugs, according to the pharmaceutical marketplace’s CEO Doug Hirsch. The agreement allows Dashers access to GoodRX’s Gold program in order to purchase prescription drugs at discounted rates in pharmacies throughout the U.S.

According to a 2019 Study led by Upwork and Freelancers Union, over 57 million Americans are freelancers.

“All Americans need more access to affordable healthcare,” said Hirsch. “Last year, we expanded our GoodRx Gold offering beyond exclusive discounts on prescriptions to include telehealth and mail delivery so patients can access affordable and convenient care along every step of their healthcare journey. Now, we’re excited to provide Dashers with a more affordable way to access Gold savings so these hard working Americans can receive the care they need at a price they can afford.”

The deal made with DoorDash is much like the agreement GoodRX struck to aid USAA members, which assists military veterans as well as their families with insurance and other financial needs.

“We’re focused on trying to serve not just American consumers, but organizations [and] employers — anyone that basically is finding these pain points and wants to have a healthy population,” Hirsch said in a “Mad Money” interview.

Furthermore, through GoodRX dashers will have access to virtual doctor visits and prescriptions delivered by mail at no cost, the company said in a press release. GoodRX asserts that its Gold program can help people and families save thousands of dollars per year on prescription costs.

GoodRX shares increased 2.35% to USD33.14 on Thursday. Nevertheless, the stock has fallen 18% year to date.

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!